Skip to main content

2 Result(s)

within Eszter Gorka Remove this filter

and

  1. No Access

    Article

    Efficacy of Vemurafenib Treatment in 43 Metastatic Melanoma Patients with BRAF Mutation. Single-Institute Retrospective Analysis, Early Real-Life Survival Data

    BRAF inhibitor vemurafenib achieved improved overall survival over chemotherapy and have been approved by the FDA and EMA for the treatment of BRAF-mutated metastatic melanoma. The aim of our retrospective ana...

    Kata Czirbesz, Eszter Gorka, Tímea Balatoni, Gitta Pánczél… in Pathology & Oncology Research (2019)

  2. No Access

    Article

    Dabrafenib Therapy in 30 Patients with Melanoma Metastatic to the Brain: a Single-centre Controlled Retrospective Study in Hungary

    Dabrafenib is a potent BRAF inhibitor, which showed intracranial tumor activity. The purpose of our retrospective analysis was to evaluate the efficacy of dabrafenib for patients with melanoma brain metastasis...

    Eszter Gorka, Dániel Fabó, András Gézsi, Kata Czirbesz… in Pathology & Oncology Research (2018)